| Terumo Europe in Heverlee (Belgium) recognised again as ‘Factory of the Future’ | https://www.terumo-europe.com/en-emea/news/terumo-europe-in-heverlee-(belgium)-recognised-again-as-‘factory-of-the-future’ | Terumo Europe in Heverlee (Belgium) recognised again as ‘Factory of the Future’ | | 2/10/2026 11:00:00 PM | <h4 style="text-align:justify;">Terumo Europe’s production site has once again been recognised as a Factory of the Future (2026–2028), a title awarded by Agoria and Sirris. Following the previous award for 2022–2025, this renewed recognition confirms the site’s continued evolution. At the Heverlee location, Terumo primarily manufactures injection needles and injection solutions for healthcare professionals and patients worldwide. This recognition aligns with Terumo’s mission of contributing to society through healthcare.<br></h4> |
| Terumo Selected as an “A-List” Company in Both “Climate Change” and “Water Security” Categories of CDP2025 | https://www.terumo-europe.com/en-emea/news/terumo-selected-as-an-a-list-company-in-both-climate-change-and-water-security-categories-of-cdp2025 | Terumo Selected as an “A-List” Company in Both “Climate Change” and “Water Security” Categories of CDP2025 | | 1/7/2026 11:00:00 PM | <p style="text-align:justify;">Terumo Corporation (TSE: 4543) announced that Terumo Group has been named by CDP*<sup>1</sup> to the “A-List” in both the Climate Change and Water Security categories of CDP2025. This is the first time Terumo has achieved the highest rating in both categories.<br></p> |
| Terumo Announces MDR Certification for CDI OneView™ Monitoring System | https://www.terumo-europe.com/en-emea/news/terumo-announces-mdr-certification-for-cdi-oneview™-monitoring-system | Terumo Announces MDR Certification for CDI OneView™ Monitoring System | | 10/20/2025 10:00:00 PM | <p>CDI OneView™ Monitoring System is a next generation modular, expandable design that displays in real time up to 22 vital patient parameters.<br></p> |
| Terumo Announces Completion of Acquisition of WuXi Biologics Drug Product Plant in Leverkusen, Germany | https://www.terumo-europe.com/en-emea/news/terumo-announces-completion-of-acquisition-of-wuxi-biologics-drug-product-plant-in-leverkusen-germany | Terumo Announces Completion of Acquisition of WuXi Biologics Drug Product Plant in Leverkusen, Germany | | 9/30/2025 10:00:00 PM | <p>Expansion of Terumo’s CDMO Production Capacity and Global Responsiveness<br></p> |
| TERUMO ANNOUNCES COMMERCIAL LAUNCH OF THE IMMUCISE™ INTRADERMAL INJECTION SYSTEM | https://www.terumo-europe.com/en-emea/news/terumo-announces-commercial-launch-of-the-immucise™-intradermal-injection-system | TERUMO ANNOUNCES COMMERCIAL LAUNCH OF THE IMMUCISE™ INTRADERMAL INJECTION SYSTEM | | 7/1/2025 10:00:00 PM | |
| Terumo Initiates Liquidation Proceedings for Quirem Medical | https://www.terumo-europe.com/en-emea/news/terumo-initiates-liquidation-proceedings-for-quirem-medical | Terumo Initiates Liquidation Proceedings for Quirem Medical | | 6/26/2025 10:00:00 PM | <p>Terumo Corporation (TSE: 4543) today announced that it has initiated liquidation proceedings for Quirem Medical B.V., its wholly owned subsidiary in the Netherlands. Quirem develops and manufactures radiation-emitting beads used in interventional oncology (catheter-based liver cancer treatment).<br></p> |
